Evofem Biosciences, Inc.
EVFM$1M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO32 employees
Drugs in Pipeline
4
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EVFM News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
AMPHORA
Contraception
Conceptrol
Contraception
EVO100
Sexually Transmitted Diseases
LIPO-202
Central Abdominal Bulging
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AMPHORA | Phase 3 | Contraception | - | - |
Conceptrol | Phase 3 | Contraception | - | - |
EVO100 | Phase 3 | Sexually Transmitted Diseases | - | - |
LIPO-202 | Phase 3 | Central Abdominal Bulging | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply